Lung Transplant: Clinical Trials

5 trials for Lung Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 21Withdrawn 1

Follow Lung Transplant: new trials by email Literature Review of Lung Transplant trials Research Report on Lung Transplant

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Protek Solo Transseptal Cannula - Lung Transplant, Pulmonary Hypertension
Phase 1RecruitingMayo Clinic42026-12-112026-07-31
PRETELL: PREvention of TELomere-related Complications After Lung Transplant
Danazol Pill, Placebo - Short Telomere Length, Lung Transplant
Phase 1 / Phase 2WithdrawnBrigham and Women's Hospital2021-01-012023-02-15
Expanding the Pool in Lung Transplantation
Epclusa - Hepatitis C, Lung Transplant
Phase 1CompletedPablo Sanchez102019-07-302022-12-16
Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0
Ascorbic Acid - Lung Transplant
Phase 1CompletedDuke University62017-12-112019-07-05
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
Regadenoson infusion - Lung Transplant
Phase 1UnknownChristine Lau, MD212017-11-302020-06-04

Narrower conditions

Heart Failure (1)  ·  Hepatitis C (1)  ·  Hypertension, Pulmonary (1)  ·  Leukopenia (1)

Broader conditions

Blood-Borne Infections (1)  ·  Cardiovascular Diseases (1)  ·  Communicable Diseases (1)  ·  Cytopenia (1)  ·  Digestive System Diseases (1)  ·  Flaviviridae Infections (1)  ·  Heart Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Hypertension (1)  ·  Infections (1)  ·  Leukocyte Disorders (1)  ·  Liver Diseases (1)

Interventions

Ascorbic Acid (1)  ·  Danazol (1)  ·  Methods (1)  ·  sofosbuvir-velpatasvir drug combination (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Christine Lau, MD (1)  ·  Duke University (1)  ·  Mayo Clinic (1)  ·  Pablo Sanchez (1)

Countries

United States (4)

Top investigators

Christine Lau, MD (1)  ·  Ian Makey, MD (1)  ·  Lorenzo Zaffiri, MD (1)  ·  Mohammad E Alomari, MD (1)  ·  Omar Mohamedaly, MD (1)  ·  Pablo Sanchez, MD (1)

Results publications

PMID 32503727

NIH funding

R01HL128492 (1)